Ocular complications of adjuvant interferon therapy for malignant melanoma: A review;Übersicht zu interferon-nebenwirkungen am auge bei adjuvanter melanomtherapie

Hautarzt

Volumn 54, Issue 2, 2003, Pages 144-147

  Ockenfels, H M ^a,b   Lisch, W ^a  

^a Haut und Allergieklinik   (Germany)

^b NONE   (Germany)

Author keywords

Interferon; Melanoma; Retinopathy

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; EYE DISEASE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PATIENT EDUCATION; PATIENT MONITORING; RETINA ISCHEMIA; REVIEW; VISUAL IMPAIRMENT; ADJUVANT CHEMOTHERAPY; CHEMICALLY INDUCED DISORDER; RETINA DISEASE; SKIN TUMOR; VISUAL DISORDER;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; EYE DISEASES; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MELANOMA; RETINAL DISEASES; SKIN NEOPLASMS; VISION DISORDERS;

EID: 0041511802     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Bauherz G, Soeur M, Lustman F (1990) Oculomotor nerve paralysis induced by alpha-2-Interferon. Acta Neurolog Belg 90:111-114
2. Ene L, Gehenot M, Horsmans Y, Detry-Mo-Sel M. Geubel AP (1994) Transient blurred vision after interferon for chronic hepatitis C (letter). Lancet 344:827-828
3. Esmaeli B, Koller C, Papadopoulos N, Romaguera J (2001) Interferon-induced retinopathy in asymptomatic cancer patients. Ophthalmology 108:858-860
4. Gabler B, Kroher G, Bogenrieder T, Spiegel D, Preuner J, Lohmann CP (2001) Schwerer beidseitiger Sehverlust bei malignem Melanom der Haut. Ophthalmologe 98:672-673
5. Guyer DR,Tiedeman J, Lawrence A et al. (1993): Interferon-associated retinopathy. Arch Ophthalmol 111:350-356
6. Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM (2001) Retinopathy associated with high-dose interferon alpha-2b-therapy. Am J. Ophthalmol 131:782-787
7. Hoerauf H, Schmidt-Erfurth U, Asiyo-Vogel M, Laqua H (2000) Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings. Arch Ophthalmol 118:580-582
8. Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P (1999) Ocular complications with high-dose interferon alfa in chronic active hepatitis. Clin Trial 13 (Pt2)(-HD-):241-246
9. Lohmann CP, Kroher G, Bogenrieder T, Spiegel D, Preuner J (1999) Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma. Lancet 353:1326
10. Norcia F, Di Maria A, Prandini F, Redaelli C (1999) Natural interferon therapy: optic nerve ischemic damage? Ophthalmologica 213:339-340
11. Okanoue T, Sakamoto S, Itoh Y et al. (1996) Side effects of high-dose interferon therapy for chronic hepatitis C.J Hepatol 25:283-291
12. Pacifi L, Passarelli F, Papa G, Cannone L, Rossini PM (1993) Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment. Ital J Neurol Sci 14:579-580
13. Purvin VA (199S) Anterior ischemic optic neuropathy secondary tointerferon alpha. Arch Ophthalmol 113:1041-1044
14. Saito H, Ebinuma H, Nagata H et al. (2001) Interferon-associated retinopathy in a uniform regimen of a therapy for chronic hepatitis C. Liver 21:192-197
15. Taylor JL et al. (1998) The effects of interferon-α on the production and action of other cytokines. Semin Oncol 24 [Suppl]:23-29